Suppr超能文献

伐昔洛韦(阿昔洛韦的L-缬氨酸酯)与氢氧化铝镁抗酸剂之间不存在相互作用。

Lack of interaction between valaciclovir, the L-valyl ester of acyclovir, and Maalox antacid.

作者信息

de Bony F, Bidault R, Peck R, Posner J

机构信息

Department of Clinical Pharmacology, Laboratoires Wellcome, Issy les Moulineaux, France.

出版信息

J Antimicrob Chemother. 1996 Feb;37(2):383-7. doi: 10.1093/jac/37.2.383.

Abstract

Valaciclovir is rapidly and extensively converted to acyclovir. In this study we investigated the potential interaction between oral valaciclovir and Maalox. On each of three occasions 18 healthy volunteers received a single oral dose of 1000 mg valaciclovir, or 30 mL Maalox 65 min after valaciclovir administration, or 30 mL Maalox 30 min before valaciclovir. Acyclovir plasma concentrations and pharmacokinetic parameters were not significantly affected by administration of Maalox before or after valaciclovir. Therefore, there is no need for restriction of valaciclovir dosing in patients receiving antacid medication.

摘要

伐昔洛韦能迅速且广泛地转化为阿昔洛韦。在本研究中,我们调查了口服伐昔洛韦与氢氧化铝镁混悬液之间的潜在相互作用。18名健康志愿者在三个不同时段分别接受了单次口服1000mg伐昔洛韦,或在服用伐昔洛韦65分钟后服用30mL氢氧化铝镁混悬液,或在服用伐昔洛韦30分钟前服用30mL氢氧化铝镁混悬液。阿昔洛韦的血浆浓度和药代动力学参数在伐昔洛韦之前或之后服用氢氧化铝镁混悬液时均未受到显著影响。因此,接受抗酸药物治疗的患者无需限制伐昔洛韦的剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验